Elysium Health

NAD+, biological age testing, longevity supplements

consumer products

elysiumhealth.com·New York City, New York, United States·$40M total funding

01Overview 02People 03Projects 04Concepts 05Patents 06Public records 07Belief evolution

Plate C · C-GFMO

Summary · Eternal Search editorial

Elysium Health NAD+, biological age testing, longevity supplements

Elysium Health sells products focused on healthy aging and longevity, including Basis, Index Biological Age Test, Creatine+, Matter, Signal, Format, Mosaic, Vision, and Senolytic Complex. The site emphasizes aging research, human clinical trials, scientific advisors, and research collaborations with Oxford and Yale. Its Aging Research Center invites participation in research.

The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →

Plate C·01 · Scientific profile

All 16 dimensions
on the record.

Composite31

Chain scale100 pts

Dimensions16

Plate C·02 · Where it sits among peers

Score vs. proximity
to longevity goals.

Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.

Reading

Elysium Health — Early mechanism · Lower middle. Derived deterministically from 16 extracted project(s). Most-advanced status: preclinical. Band: early_mechanism. Aging-relevance not LLM-reviewed in this pass.

Source: Deterministic

At a glance

Webelysiumhealth.com

HQNew York City, New York, United States

Publications

25 on file

012026Pregnancy precipitates metabolic imbalance and accelerates death in an animal model of mitochondrial cardiomyopathy.Molecular metabolism→022026Nicotinamide riboside and pterostilbene reduces frequency and severity of undesirable symptoms of the menopause transition: an open-label, pilot clinical trialFrontiers in Aging→032024Effect of nicotinamide riboside on airway inflammation in COPD: a randomized, placebo-controlled trial.Nature aging→042024Elevated homocysteine is associated with increased rates of epigenetic aging in a population with mild cognitive impairmentAging Cell→052024Inhibition of <scp>UVB</scp> radiation‐induced tissue swelling and immune suppression by nicotinamide riboside and pterostilbenePhotodermatology Photoimmunology & Photomedicine→062023Defining NAD(P)(H) CatabolismNutrients→072023Nicotinamide riboside and pterostilbene reduces markers of hepatic inflammation in NAFLD: A double-blind, placebo-controlled clinical trial.Hepatology (Baltimore, Md.)→082023Nicotinamide riboside, pterostilbene and ibudilast protect motor neurons and extend survival in ALS miceNeurotherapeutics→092022Intravenous nicotinamide riboside elevates mouse skeletal muscle NAD+ without impacting respiratory capacity or insulin sensitivity.iScience→102022A computational solution for bolstering reliability of epigenetic clocks: Implications for clinical trials and longitudinal tracking.Nature aging→112022A randomized placebo-controlled trial of nicotinamide riboside and pterostilbene supplementation in experimental muscle injury in elderly individuals.JCI insight→122022Gene expression profiles in sporadic ALS fibroblasts define disease subtypes and the metabolic effects of the investigational drug EH301.Human molecular genetics→132022Combination of natural polyphenols with a precursor of NAD+ and a TLR2/6 ligand lipopeptide protects mice against lethal γ radiationJournal of Advanced Research→142021NAD+ Precursors and Antioxidants for the Treatment of Amyotrophic Lateral SclerosisBiomedicines→152021A computational solution for bolstering reliability of epigenetic clocks: Implications for clinical trials and longitudinal trackingbioRxiv (Cold Spring Harbor Laboratory)→162021A randomized placebo-controlled clinical trial of Nicotinamide Riboside and Pterostilbene supplementation in experimental muscle injury in elderly subjectsmedRxiv→172021Pterostilbene in Cancer TherapyAntioxidants→182020Safety Assessment of High-Purity, Synthetic Nicotinamide Riboside (NR-E) in a 90-Day Repeated Dose Oral Toxicity Study, With a 28-Day Recovery Arm.International journal of toxicology→192020Nicotinamide riboside with pterostilbene (NRPT) increases NAD+ in patients with acute kidney injury (AKI): a randomized, double-blind, placebo-controlled, stepwise safety study of escalating doses of NRPT in patients with AKIBMC Nephrology→202019Oxidative stress and antioxidants in the pathophysiology of malignant melanoma.Biological chemistry→212019Efficacy and tolerability of EH301 for amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled human pilot studyAmyotrophic Lateral Sclerosis and Frontotemporal Degeneration→2220181121 Oral administration of nicotinamide riboside (NR) and pterostilbene (PT) to mice inhibits ultraviolet radiation-induced tissue swelling in miceJournal of Investigative Dermatology→232018Erratum: Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study.NPJ aging and mechanisms of disease→242017Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.Journal of medicinal chemistry→252017Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled studynpj Aging and Mechanisms of Disease→

Loading

Loading section...

0-100 chain-logic scale · 15 dimensions · scored on public evidence

Elysium Health

All 16 dimensionson the record.

Score vs. proximityto longevity goals.

Publications

Loading

All 16 dimensionson the record.

Score vs. proximityto longevity goals.

Publications

All 16 dimensions
on the record.

Score vs. proximity
to longevity goals.

All 16 dimensions
on the record.

Score vs. proximity
to longevity goals.